Patricia L. Allen
Patricia L. Allen occupies the position of Chief Financial Officer at Vividion Therapeutics, Inc. Ms. Allen is also on the board of 7 other companies.
In the past Ms. Allen occupied the position of Chief Financial Officer, Treasurer & VP at Alnylam Pharmaceuticals, Inc., Finance Director of Alkermes, Inc., CFO, Treasurer & Principal Accounting Officer at Zafgen, Inc. and Auditor at Deloitte & Touche LLP.
Patricia L. Allen received an undergraduate degree from Bryant University.
Transactions
Date
Transaction
Value
| 06/05/2020 | 5,635 | Disposition at $55.9 per share. | 314,997 |
| 06/05/2020 | 5,635 | Derivative/Non-derivative trans. at $25.73 per share. | 144,988 |
| 06/03/2020 | 6,365 | Disposition at $59.14 per share. | 376,427 |
| 06/03/2020 | 6,365 | Derivative/Non-derivative trans. at $25.73 per share. | 163,771 |
| 01/24/2020 | 700 | Disposition at $67.36 per share. | 47,152 |
| 01/24/2020 | 6,496 | Disposition at $66.55 per share. | 432,309 |
| 01/24/2020 | 17,804 | Disposition at $65.93 per share. | 1,173,818 |
| 01/24/2020 | 25,000 | Derivative/Non-derivative trans. at $3.95 per share. | 98,750 |
